Clinical Trial Update: Pharmacokinetics of Two Extended-Release Formulations of Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 pharmacokinetic study evaluating two extended-release formulations of methylphenidate in children with ADHD has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• methylphenidate extended-release (methylphenidate)

Snippet

Sponsor: University Hospital Freiburg | Conditions: Attention Deficit Hyperactivity Disorder | Phase 1, Phase 2 | Status: COMPLETED